Monday, May 10, 2010
Fate Therapeutics Names VP
San Diego-based Fate Therapeutics, a developer of stem cell biology technology, announced today that it has named Tom Novak as the firm's Vice President of Research and Drug Discovery. Novak was msot recently Senior Director and Head of Discovery Technologies at Roche. He has also worked at Wyeth. The firm said Novak will be responsible for drug discovery and development activities for the firm's "stem cell modulator" products. Fate Therapeutics is venture backed by OVP, Astellas Venture Management, Genzyme Ventures, ARCH Venture Partners, Polaris Venture Partners and Venrock.